Fig. 1From: Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factorsOverall survival for the whole group of patients. No significant difference was found in overall survival between patients who did and did not receive concurrent chemotherapy (P = 0.060)Back to article page